Symposium – CKD and Cardiovascular Risks 26 November 2026 – Free
Live Webinar
26 November 2026 | 19:00 – 20:15 | Free
BOOK HERE
Agenda
Lecture One – 19:00 – 19:45
Test the Urine, Protect the Heart: Reframing CV Risk through uACR
This educational session has been developed, organised, and funded by Boehringer Ingelheim for UK healthcare professionals. The speaker has received an honorarium for delivering this presentation (NP-GB-107918 September 2026). For UK Healthcare Professionals only.
As the discussion unfolds, we will explore how chronic kidney disease (CKD) and cardiovascular disease (CVD) intersect. Moreover, explain why early urine testing matters and how uACR reveals hidden cardiovascular threats.
Throughout the lecture, participants will discover who to test, when to act, and why early intervention changes outcomes. In addition, the session highlights how delayed action increases long‑term risk. Consequently, clinicians will leave with practical strategies to integrate kidney markers into cardiovascular care.
Learning Focus
- Why should I care about CVD in the context of CKD?
- What does UACR tell me about my patients’ cardiovascular risk?
- Who should I be testing, and how?
- What happens if we don’t act early?
Dr Fozia Ahmed
Consultant Cardiologist, Manchester Royal Infirmary
Lecture Two – 19:45 – 20:15
Do Kidneys really matter in Diabetes?
Judy Winter, ANP and Nurse Trainer, leads an independent session emphasising kidney health in diabetes. She explains how diabetic kidney disease develops silently yet seriously. Furthermore, she outlines how routine monitoring using eGFR and urine ACR detects early damage.
Then, she discusses interventions that slow progression—covering glucose control, blood pressure management, and kidney‑protective treatments. Equally important, she shows how patients can engage in screening and self‑management. As a result, healthcare professionals gain actionable knowledge to preserve kidney function and improve outcomes.
Ultimately, both lectures connect cardiovascular and renal care, bridging disciplines and encouraging proactive testing. Hence, this agenda supports continuous learning and collaboration across UK healthcare.
1. Explain why the kidneys really do matter in diabetes and recognise diabetic kidney disease as a potentially serious but often silent complication.
2. Understand the importance of routine kidney monitoring and describe the role of eGFR and urine ACR in detecting kidney damage.
3. Identify the key factors that contribute to the development and progression of kidney disease in diabetes.
4. Discuss the interventions that can slow or prevent the progression of diabetic kidney disease, including glucose management, blood pressure management and appropriate kidney-protective treatments.
5. Recognise how people with diabetes can actively participate in preserving their kidney function through screening, self-management and early intervention
Judy Winter – ANP and Nurse Trainer
Judy Winter has had no input from the sponsoring company and has full editorial rights over their presentation.
Don’t forget to visit our course calendar to see how we can support your professionals development, or whynot visit our snippets and blog pages to enhance your knowledge and CPD
